| Structure | Details |
|---|---|
|
|
Product Name: Flavopiridol Order number: RT-R09-149 CAS: 146426-40-6 Purity: >=95% Appearance: MF: C21H20ClNO5 MW: 401.843 MP: 169.5 oC (HCl, M.I.) oC Description: This substance inhibits cyclin-dependent kinases (CDKs) by competing with adenosine triphosphate (ATP) for the active site of each kinase. |
|
|
Product Name: 2-Bromo-1-tetralone Order number: RT-R09-150 CAS: 13672-07-6 Purity: >=95% Appearance: solid MF: C10H9BrO MW: 225.085 MP: 39 oC Description: The bromoketone is a useful building block in organic chemistry. |
|
|
Product Name: Lenalidomide Order number: RT-R09-153 CAS: 191732-72-6 Purity: >=95% Appearance: solid MF: C13H13N3O3 MW: 259.265 MP: n.a. oC Description: This substance modulates substrate specificity of the CRL4CRBN E3 ubiquitin ligase, causing these transcriptional factors to break down. |
|
|
Product Name: Docetaxel trihydrate Order number: RT-R09-154 CAS: 148408-66-6 Purity: >=95% Appearance: solid MF: C43H59NO17 MW: 861.935 MP: 232 (M.I.) oC Description: This inhibitor of microtubular deploymerization also interacts with bcl-2/bcl-xL gene expression. |
|
|
Product Name: D,L-Dihydroorotic acid Order number: RT-R1-155 CAS: 6202-10--4 Purity: >=95% Appearance: solid MF: C5H6N2O4 MW: 158.113 MP: n.a. oC Description: This is a racemic mixture of L and D isomers of dihydroorotic acid. |
|
|
Product Name: L-Dihydroorotic acid Order number: RT-R1-168 CAS: 5988-19-2 Purity: >=95% Appearance: solid MF: C5H6N2O4 MW: 158.113 MP: 254 oC Description: L-Dihydroorotic acid exists in living organisms. It is implicated in the metabolic disorder called the beta-ureidopropionase deficiency pathway. |